Dziankowska-Bartkowiak B, Lutowiecka-Wranicz A, Sysa-Jedrzejowska A, Torzecka D, Waszczykowska E
Samodzielnej Pracowni Immunodermatologii AM w Lodzi.
Przegl Dermatol. 1990 Sep-Oct;77(5):332-5.
The purpose of the study was evaluation of the clinical usefulness of determination of antibodies to soluble nuclear antigens. The study was carried out in 71 cases of various collagen diseases. Antibodies dsDNA (IIF method with Crithidium luciliae as substrate) were found only in patients with SLE and renal involvement. RNP antibodies (double immunodiffusion method) were demonstrated in 83.3% of cases of mixed connective tissue disease, and Sm antibodies in 8% of SLE patients. It is worth stressing that in the presented material Sm antibodies were present only in association with RNP antibodies. Antibodies Ro and/or La were present most often in the sera of patients with SCLE, while Scl 70 antibodies were a marker of systemic sclerosis, more frequent in patients with diffuse scleroderma, while their demonstration in acroscleroderma suggested a more severe course of the disease. The study showed a high diagnostic and prognostic value of antibodies to soluble nuclear antigens in collagen diseases.
本研究的目的是评估可溶性核抗原抗体检测的临床实用性。该研究对71例各种胶原病患者进行。双链DNA抗体(以利什曼原虫为底物的间接免疫荧光法)仅在患有系统性红斑狼疮(SLE)且有肾脏受累的患者中发现。核糖核蛋白(RNP)抗体(双向免疫扩散法)在83.3%的混合性结缔组织病病例中得到证实,而Sm抗体在8%的SLE患者中出现。值得强调的是,在本研究材料中,Sm抗体仅与RNP抗体同时存在。Ro和/或La抗体最常出现在亚急性皮肤型红斑狼疮(SCLE)患者的血清中,而Scl 70抗体是系统性硬化症的标志物,在弥漫性硬皮病患者中更常见,而在肢端硬皮病中检测到该抗体提示疾病进程更严重。该研究表明可溶性核抗原抗体在胶原病中具有较高的诊断和预后价值。